Novavax to Attend BofA Securities 2025 Healthcare Gathering in Las Vegas

Novavax to Attend BofA Securities 2025 Healthcare Gathering

Novavax, Inc. (Nasdaq: NVAX), a leading biotechnology firm, has announced its participation in the anticipated BofA Securities 2025 Health Care Conference, scheduled to take place on May 14, 2025, in Las Vegas, Nevada. This conference serves as a significant platform for industry leaders to discuss advancements, innovations, and collaborative opportunities within the healthcare sector.

Conference Details

The conference will feature a fireside chat from 3:00 to 3:30 p.m. Pacific Time (PT), where Novavax representatives will engage with investors and industry experts. Notably, a live webcast of this discussion will be accessible on the company's website for those unable to attend in person. Additionally, a replay of the webcast will remain available on their Events and Presentations page for a full 30 days following the event.

Novavax is recognized for its pioneering work in the biotechnology space, particularly in vaccine development. With an innovative approach that integrates protein-based nanoparticles along with its proprietary Matrix-M® adjuvant, the company aims to tackle some of the most pressing health challenges globally. Their strategic vision focuses on building diverse partnerships through out-licensing agreements, enabling them to extend their technology and vaccine platforms.

Connect with Novavax

This conference provides an excellent opportunity for stakeholders to learn about Novavax's progress and future initiatives. Investors and media representatives are encouraged to connect with Novavax’s team during the event. For media inquiries, representatives can contact Giovanna Chandler at (202) 709-5563, while investors can reach out to Luis Sanay, CFA, at (240) 268-2022.

About Novavax

Established with a mission to pioneer vaccine technology, Novavax, Inc. primarily focuses on infectious diseases. By spearheading research and investing smartly in an expanding pipeline, they strive for excellence and innovation in vaccine efficacy. The forthcoming events at the BofA Securities Conference will shed light on their operational strategies and collaborative ventures, reinforcing their commitment to global health.

For more details about Novavax and their leading-edge vaccine developments, visit their official website or their LinkedIn profile.

Conclusion

The BofA Securities 2025 Health Care Conference is a crucial event in the health care calendar, one that highlights advancements in medical technology, pharmaceuticals, and the overall healthcare ecosystem. Novavax’s participation underlines its efforts to engage with stakeholders and further its strategic partnerships aimed at improving health outcomes worldwide. Investors and health enthusiasts alike await the insights that will be shared during this event, marking a step forward in discussions around innovative healthcare solutions.